These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 210311)

  • 21. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
    Parfitt AM; Kleerekoper M; Cruz C
    Miner Electrolyte Metab; 1986; 12(5-6):356-62. PubMed ID: 3543637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
    Bikle DD; Herman RH
    J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
    Prié D; Ravery V; Boccon-Gibod L; Friedlander G
    Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal phosphate control as a reliable predictive factor of stone recurrence.
    Kim YJ; Kim TH; Yun SJ; Kim ME; Kim WJ; Lee SC
    J Urol; 2009 Jun; 181(6):2566-72; discussion 2572. PubMed ID: 19375105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC; Bower RH; Sode J
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical changes before and during oral calcium tolerance test in calcium stone formers.
    Kitamura T; Hirano Y; Ueda D; Aso Y
    Urol Res; 1988; 16(3):149-55. PubMed ID: 2842910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone in urinary stone patients.
    Khanam A; Rahman MA
    Mol Cell Biochem; 1993 Apr; 121(1):1-4. PubMed ID: 8510669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnesium status in idiopathic calcium urolithiasis--an orientational study in younger males.
    Schmiedl A; Schwille PO
    Eur J Clin Chem Clin Biochem; 1996 May; 34(5):393-400. PubMed ID: 8790974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high level bovine parathyroid extracts on serum PTH, cAMP and urinary cAMP, Na+, and uric acid in stone-forming patients.
    Dunzendorfer U; Knöner M
    Eur Urol; 1982; 8(6):363-6. PubMed ID: 6291949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
    Malberti F; Farina M; Imbasciati E
    Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
    Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T
    Nephron; 1991; 59(2):226-31. PubMed ID: 1659670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism.
    Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M
    J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements.
    Benson L; Ljunghall S; Groth T; Falk H; Hvarfner A; Rastad J; Wide L; Akerström G
    Ups J Med Sci; 1987; 92(2):147-76. PubMed ID: 2889282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endocrinological studies on pathogenesis of urolithiasis. II. Cyclic AMP as an index of parathyroid function in primary hyperparathyroidism (author's transl)].
    Kohri K; Yachiku S; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1980 Jun; 71(6):626-37. PubMed ID: 6253703
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictors of recurrent hyperparathyroidism after total parathyroidectomy in chronic renal failure.
    Stratton J; Simcock M; Thompson H; Farrington K
    Nephron Clin Pract; 2003; 95(1):c15-22. PubMed ID: 14520017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis, occurrence and clinical aspects of primary hyperparathyroidism in patients with recurrent urolithiasis as registered in general practice.
    Laerum E; Borchgrevink CF; Gautvik KM; Aune S
    Scand J Prim Health Care; 1985 Nov; 3(4):207-13. PubMed ID: 4081402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urinary oxalate in recurrent calcium urolithiasis with and without hyperfunctioning parathyroid glands and in healthy controls. influence of age and season (author's transl)].
    Schwille PO; Paulus M; Scholz D; Sigel A; Wilhelm E
    Urologe A; 1979 Jul; 18(4):215-24. PubMed ID: 473457
    [No Abstract]   [Full Text] [Related]  

  • 39. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
    Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
    J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary 3',5'-cyclic adenosine monophosphate in relation to serum and urinary calcium in acromegaly and primary hyperparathyroidism.
    Halse J
    Acta Endocrinol (Copenh); 1980 Aug; 94(4):468-74. PubMed ID: 6254299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.